We are proud to announce the official launch of Qritive Academy, a dedicated online platform designed to support continuous learning and professional development in the field of pathology. Developed with the mission to make high-quality education more accessible to pathologists worldwide, the platform offers both foundational and advanced content tailored to today’s diagnostic needs.

Singapore, Aug 21, 2025  — Qritive is proud to announce that Dr Lal PathLabs, one of India’s leading diagnostic providers, has selected...

Qritive is proud to announce that its AI-powered diagnostic solution, QAi Prostate Grade, has received Class C In Vitro Diagnostic (IVD) registration from Singapore’s Health Sciences Authority (HSA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics. 

Qritive is pleased to announce that its AI-powered solution, QAi Prostate Grade, has received official market approval from the Department of Health – Abu Dhabi following a comprehensive Health Technology Assessment (HTA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics. 

Singapore, July 1, 2025  — Qritive is proud to be selected as an awardee of the Japan Smart Healthy Aging QuickFire Challenge, an...

Singapore, March 25, 2025  — Qritive was honored with the Innovation Award 2024 at the AI Trailblazers programme, presented by Google...

Singapore, September 12, 2024 — Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its...

Qritive Pte. Ltd. is now ISO/IEC 27001:2022 certified